Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Battling Negative Image Of Generics In Japan (Part 2 of 2)

This article was originally published in PharmAsia News

Executive Summary

[Editor's note: This is part two of a two-part feature on obstacles in promoting generics in Japan. Part one, which explored negative connotations associated with with the term "generic," appeared in PharmAsia News, March 19, 2009.]
Advertisement

Related Content

Japan's Pharma Companies Should Consolidate, Says Bayer Yakuhin Chairman
Japan Generic Drugs Show Only Minor Quality Problems, Ministry Study Shows
Frustration Drives Japan To Allow Generics Before Side Patents Expire
Teva-Kowa Faces Uphill Battle With Japanese Domestic And Foreign Generic Drug Makers
Despite Global Financial Crisis, China Pharma Market Expected To Grow At 20% Over Next Several Years
Wide Data Gap On Generics Use In Japan Puts Damper On MHLW 30% Generic Target
Battling Negative Image Of Generics In Japan
Battling Negative Image Of Generics In Japan
Teva And Kowa Partner For 50-50 Stake In Japanese Generic Firm
Japan’s Daiichi Sankyo In “Transformational” Deal to Buy Majority Stake In India’s Ranbaxy Labs
Advertisement
UsernamePublicRestriction

Register

SC071168

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel